Is amyotrophic lateral sclerosis a primary astrocytic disease?

Medical Hypotheses

Volumn 79, Issue 6, 2012, Pages 819-822

  Sica, Roberto E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; PRION PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN STEM; ENDOPLASMIC RETICULUM STRESS; EXCITOTOXICITY; HUMAN; INFLAMMATION; METABOLISM; MOTONEURON; MOTOR CORTEX; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATIVE STRESS; PROTEIN FOLDING; PYRAMIDAL SIGN; SPINAL CORD;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; ASTROCYTES; HUMANS; MODELS, THEORETICAL;

EID: 84869082837     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.08.036     Document Type: Article

References (72)

1. Sica R.E., De Nicola A.F., Gonzalez Deniselle M.C., et al. Sporadic amyotrophy lateral sclerosis: new hypothesis regarding its aetiology and pathogenesis suggests that astrocytes might be the primary target hosting a still unknown external agent. Arq Neuropsiquiatr 2011, 69:699-706.
2. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995, 38:73-84.
3. Sattler R., Rothstein J.D. Regulation and dysregulation of glutamate transporters. Handb Exp Pharmacol 2006, 175:277-303.
4. Salazar-Grueso E.F., Roos R.P. Amyotrophic lateral sclerosis and virus. Clin Neurosci 1995, 3:360-367.
5. Mattson M.P. Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 2004, 3:105-120.
6. Zil'ber L.A., Bajdakova Z.L., Gardas'jan A.N., Konovalov N.V., Bunina T.L., Barabadze E.M. Study of the aetiology of amyotrophic lateral sclerosis. Bull WHO 1963, 29:449-456.
7. Mc Gowan D.J., Scelsa S.N., Imperato T.E., Liu K.N., Baron P., Polsky B. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS. Neurology 2007, 68:1944-1946.
8. Rowland L.P. HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia. Acta Myol 2011, 30:29-31.
9. Steele A.J., Al-Chabali A., Ferrante K., Cudkowicz M.E., Brown R.H., Garson J.A. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology 2005, 64:454-458.
10. Douville R., Liu J., Rothstein J., Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol 2011, 69:141-151.
11. Matias Guiu J., Garcia Ramos G., Galan L., Vela A., Guerrero A. Analytic epidemiological information of amyotrophic lateral sclerosis. Neurologia 2008, 23:168-178.
12. Mc Guire V., Longstreth W.T., Nelson L.M., et al. Occupational exposures and amyotrophic lateral sclerosis. A population based case-control study. Am J Epidemiol 1997, 145:1076-1088.
13. Weisskoft M.G., Morozoba N., O'Reilly E.J., et al. Prospective study of chemical exposures and amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2009, 80:558-561.
14. Karamyan V.T., Speth R.C. Animal models of BMAA neurotoxicity: a critical review. Life Sci 2008, 82:233-246.
15. Cox P.A., Richer R., Metcalf J.S. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf war veterans. Amyotroph Lateral Scler 2009, 2:109-117.
16. Gordon P.H., Rowland L.P., Youbger D.S., et al. Lymphoproliferative disorders and motor neuron disease: an update. Neurology 1997, 48:1671-1678.
17. Johansen C., Olsen J.H. Mortality from amyotrophic lateral sclerosis, other chronic disorders, and electric shocks among utility workers. Am J Epidemiol 1998, 148:362-368.
18. Beretta S., Carri M.T., Beghi E., Chio A., Ferrarese C. The sinister side of Italian soccer. Lancet Neurol 2003, 2:656-657.
19. Harwood C.A., McDermot C.J., Shaw P.J. Physical activity as an exogenous risk factor in motor neuron disease: a review of the evidence. Amyotroph Lateral Scler 2009, 10:191-204.
20. Morozova N., Weisskopf M.G., Mc Cullough M.L., et al. Diet and amyotrophic lateral sclerosis. Epidemiology 2008, 19:324-337.
21. Okouchi M., Ekshyyan O., Maracine M., Aw T.Y. Neuronal apoptosis in neurodegeneration. Antioxid Redox Signal 2007, 9:1059-1096.
22. Gonzalez Deniselle M.C., Lopez-Costa J.J., Saavedra J.P., et al. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol Dis 2002, 11:457-468.
23. Parpura V., Verkhratsky A. The astrocyte excitability brief: from receptors to gliotransmission. Neurochem Int 2011, [Epub ahead of print].
24. 2+-dependent exocytotic release of glutamate from rat cortical astrocytes. ASN Neuro 2012, 4(1). pii: e00075, http://dx.doi.org/10.1042/AN20110059, [Epub ahead of print].
25. Mishima T., Hirase H. In vivo intracellular recording suggests that gray matter astrocytes in mature cerebral cortex and hippocampus are electrophysiologically homogeneous. J Neurosci 2010, 30:3093-3100.
26. Shigetomi E., Kracun S., Khakh B.S. Monitoring astrocyte calcium microdomains with improved membrane targeted GCaMP reporters. Neuron Glia Biol 2010, 16:1-9.
27. Ekestern E. Neurotrophic factors and amyotrophic lateral sclerosis. Neurodegener Dis 2004, 1:88-100.
28. Sidoryk-Wegrzynowicz M., Wegrzynowicz M., Lee E., Bowman A.B., Aschner M. Role of astrocytes in brain function and disease. Toxicol Pathol 2011, 39:115-123.
29. Hewett J.A. Determinants of regional and local diversity within the astroglial lineage of the normal central nervous system. J Neurochem 2009, 110:1717-1736.
30. Freeman M.R. Specification and morphogenesis of astrocytes. Science 2010, 330:774-778.
31. Magistretti P.J. Neuron-glia metabolic coupling and plasticity. Exp Physiol 2011, 96:407-410.
32. Garcia M., Vecino E. Role of Muller glia in neuroprotection and regeneration in the retina. Histol Histopathol 2003, 18:1205-1218.
33. Lupien C.B., Salesse C. Identification of genes specifically expressed by human Muller cells by use of subtractive hybridization. Mol Vis 2007, 13:1828-1841.
34. Lopez-Juarez A. Bergmann glia receptors and transporters: possible roles in cerebellum physiology. Rev Neurol 2008, 47:527-535.
35. Yang W.W., Sidman R.L., Taksir T.V., et al. Relationship between neuropathology and disease progression in the SOD1 (G93A) ALS mouse. Exp Neurol 2011, 227:287-295.
36. Papadimitriou D., Le Verche V., Jacquier A., Burcin I., Przedborski S., Diane B. Inflammation in ALS and SMA: sorting out the good from the devil. Neurobiol Dis 2010, 37:493-502.
37. Zhao W., Beers D.R., Henkel J.S., et al. Extracellular mutant SOD1 induces microglial mediated motoneuron injury. Glia 2010, 15:231-243.
38. Hensley K., Mhatre M., Mou S., et al. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid Redox Signal 2006, 8:2075-2087.
39. Cali C., Marchaland J., Spagnuolo P., Gremion J., Bezzi P. Regulated exocytosis from astrocytes physiological and pathological related aspects. Int Rev Neurobiol 2009, 85:261-293.
40. Van Damme P., Bogaert E., Dewil M., et al. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci 2007, 104:14825-14830.
41. Pehar M., Vargas M.R., Cassina P., Barbeito A.G., Beckman J.S., Barbeito L. Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis. Neurodegener Dis 2005, 2:139-146.
42. Ravits J., Paul P., Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 2007, 68:1571-1575.
43. Ravits J., Laurie P., Fann Y., Moore D.H. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss post-mortem. Neurology 2007, 68:1572-1582.
44. Korner S., Kollewe K., Fahlbusch M., et al. Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis. Muscle Nerve 2011, 43:636-642.
45. Gargiulo Monachelli G.M., Janota F., Bettini M., Shoesmith C.L., Strong M.J., Sica R.E. Regional spread pattern predicts survival in patients with amyotrophic lateral sclerosis. Eur J Neurol 2012, [Epub ahead of print]. 10.1111/j.1468-1331.2011.03616.x.
46. Leon Monzon M.E., Illa I., Dalakas M.C. Expression of poliovirus receptor in human spinal cord and muscle. Ann N Y Acad Sci 1995, 753:48-57.
47. Elliot H.C. Studies on the motor cells of spinal cord V: poliomielitic lesions in the spinal motor nuclei in acute cases. Am J Pathol 1947, 23:313-325.
48. Esiri M.M. Poliomielitis: immunoglobulin-containing cells in the central nervous system in acute and convalescent phases of the human disease. Clin Exp Immunol 1980, 40:42-48.
49. Martin L.J. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol 1999, 58:459-471.
50. Ince P.G., Highly J.R., Kirby J., Wharton S.B., Takahashi H., Strong M.G., et al. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol 2011, 122:657-671.
51. Gordon P.H. Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management. CNS Drugs 2011, 25:1-15.
52. Corcia P., Jafari-Schluep H.F., Lardillier D., et al. A clustering of conjugal amyotrophic lateral sclerosis in south-eastern France. Arch Neurol 2003, 60:553-557.
53. Godeiro C., Oliveira A.S., Felicio A.C., Chieia M.A., Gabbai A.A. Conjugal amyotrophic lateral sclerosis in Brazil. Arq Neuropsiquiatr 2009, 67:1045-1048.
54. Goedert M., Clavaguera F., Tolnay M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci 2010, 33:317-325.
55. Polimenidou M., Cleveland D.W. The seeds of neurodegeneration: prion-like spreading in ALS. Cell 2011, 147:498-508.
56. Guest W.C., Silverman J.M., Pokrishevsky E., O'Neill M.A., Grad L.I., Cashman N.R. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit. J Toxicol Environ Health A 2011, 74:1433-1459.
57. Prudencio M., Borcchelt D.R. Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states. Mol Neurodegener 2011, 6:77-96.
58. Gendron T.F., Petrucelli L. Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration. J Mol Neurosci 2011, 45:486-499.
59. De Calignon A., Polydoro M., Suarez-Calvet M., et al. Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 2012, 73:685-697.
60. Liu L., Drouet V., Wu J.W., Witter M.P., Small S.A., Clelland C., et al. Trans-synaptic spread of tau pathology in vivo. PLoS One 2012, (2):e31302. [Epub 2012 Feb 1].
61. Perea G., Araque A. Glial calcium signalling and neuron-glia communication. Cell Calcium 2005, 38:375-382.
62. Araque A., Navarrete M. Glial cells in neuronal network function. Philos Trans R Soc Lond Biol Sci 2010, 365:2375-2381.
63. Nomby E. Prions and protein folding disease. J Intern Med 2011, 270:1-14.
64. Parchi P., Strammiello R., Giese A., Kretzschmar H. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present and future. Acta Neuropathol 2011, 121:91-112.
65. Inram M., Mahmood S. An overview of animal prion diseases. Virol J 2011, 8:493.
66. Philips T., Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 2011, 10:253-263.
67. Forsberg K., Andersen P.M., Marklund S.L., Brannstromm T. Glial nuclear aggregates of super oxide dismutase 1 are regularly present in patients with amyotrophic lateral sclerosis. Acta Neuropathol 2011, 121:623-634.
68. Wang L., Gutmann D.H., Roos R.P. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum Mol Genet 2011, 20:286-293.
69. Haidet-Phillips A.M., Hester M.E., Miranda C.J., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol 2011, 29:824-828.
70. Rodriguez G.E., Gonzalez D.M., Gargiulo-Monachelli G.M., Costa J.J., De Nicola A.F., Sica R.E. Morphological abnormalities in mitochondria of the skin of patients with sporadic amyotrophic lateral sclerosis. Arq Neuropsiquiatr 2012, 70:40-44.
71. Balkema-Buschmann A., Eiden M., Hoffmann C., et al. BSE infectivity in the absence of detectable PrP (Sc) accumulation in the tongue and nasal mucosa of terminally diseased cattle. J Gen Virol 2011, 92:476.
72. Mays C.E., Yeom J., Kang H.E., et al. In vivo amplification of misfolded prion protein using lysate of cultured cells. PloS One 2011, 6(3):e18047.